Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 52364 100 mg
Total 0 results
Nothing found
Sponsors and Collaborators
Lishui Hospital of TCM
Congressionally Directed Medical Research Programs
Aryn Knight
APT Foundation, Inc.
Private Ortopedia Hospital, Seyhan Adana
National Institute of Health and Medical Research 1061, Montpellier
Key Tech
Radiomedix, Inc.
Refocus Group, Inc.
Third Affiliated Hospital of Third Military Medical University
Francine Behar-Cohen
Richard M. Fairbanks School of Public Health AT IUPUI
Cure Cancer Worldwide Corporation
LuEsther T. Mertz Retinal Research Center
Accunea Ltd.
Central Institute of Psychiatry, Ranchi, India
Zhiwu Huang, Ph.D.
Mitaka USA, Inc.
Association for the Blind and Visually Impaired
Erol Aktunc
View Full List
Medical Conditions
Memory Disorders
Malignant Tumor of Urinary System (Disorder)
Humerus Fracture Displaced Proximal
Root Abscess
Bladder Recurrence
Poor Medication Adherence
Urinary Bladder Neurogenic Dysfunction
Anticoagulant Prophylaxis/Therapy
Endoscopic Surveillance
Neuroectodermal Tumor
Atherosclerosis Coronary Artery With Angina Pectoris
Control Nausea and Vomiting
Granulomatous Disease, Chronic
Small Intestine Cancer
Parental
0.5-14 Year Old Children With Nephroblastoma
Inoperable Stage III Non-small Cell Lung Cancer
Pharmacokinetics of Ipragliflozin
Macrocephaly Autism Syndrome
Bladder Cancer Recurrent
View Full List
Drug Interventions
Idelalisib
Cyclosporine A
Salvinorin A
Sparsentan
Biphasic insulin aspart 30
Bupropion Extended Release Oral Tablet
SAR408701 (Tusamitamab ravtansine)
Campath 1H
Everolimus
Letrozole
The drug "Rutan 0.1".
Fibrin Sealant
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
APG2575 800 mg
Varenicline Controlled Release 1.2 mg
FTD regimen
Elafibranor 80mg
Clozapine 100 mg
Ceralasertib
Vehicle
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Australia
Contract Research Organizations in Bangladesh
Contract Research Organizations in Costa Rica
Contract Research Organizations in Croatia
Contract Research Organizations in Dominican Republic
Contract Research Organizations in El Salvador
Contract Research Organizations in Hong Kong
Contract Research Organizations in Montenegro
Contract Research Organizations in Netherlands
Contract Research Organizations in Singapore
Contract Research Organizations in Sweden
Contract Research Organizations in Türkiye
CRO list by country
CROs in Congo, DR of
SGS
ACROSS Global
All CROs in Congo, DR of
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe